North Carolina's two-game winning streak has come to an end after it suffered its second loss of the season after it lost to UCF in a 34-9 blowout loss at the Acrisure Bounce House. UCF (3-0) led the ...
Specific key efficacy findings from cohort B (N=80) of the Phase 2/3 open-label, single-arm multi-center QUILT-3.032 study include: 1 The DFS rate at 12 months (primary endpoint) was 58.2% (95% CI ...
ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced treatment with ANKTIVA® (nogapendekin alfa inbakicept-pmln) plus Bacillus Calmette-Guérin (BCG) demonstrates efficacy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback